Michael E. Newman
Impact in
- Behavioral Neuroscience top 2%
- Stress Responses and Cortisol
-
- Neurotransmitter Receptor Influence on Behavior
- Neuroscience and Neuropharmacology Research
Papers in
-
- Neurotransmitter Receptor Influence on Behavior 25
- Neuroscience and Neuropharmacology Research 20
- Pharmacology 27
- Treatment of Major Depression 27
- Co-authors
- Bernard Lerer (47 shared papers)Eitan Gur (27 shared papers)Robert Haim Belmaker (10 shared papers)Eliyahu Dremencov (11 shared papers)Baruch Shapira (9 shared papers)HENRY MCILWAIN (6 shared papers)Miron Baron (1 shared paper)NEIL J. RISCH (1 shared paper)
- Journals
- Neuropharmacology (8 papers)JNCI Journal of the National Cancer Institute (7 papers)European Journal of Pharmacology (7 papers)Biochemical Pharmacology (6 papers)Psychopharmacology (4 papers)
- Partner nations
- IsraelUnited StatesUnited Kingdom
In The Last Decade
Michael E. Newman
94 papers receiving 2.5k citations
Peers
Comparison fields: 5 of 93
- Behavioral Neuroscience 205
- Cellular and Molecular Neuroscience 923
- Pharmacology 623
- Psychiatry and Mental health 739
- Physiology 156
Countries citing papers authored by Michael E. Newman
This map shows the geographic impact of Michael E. Newman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael E. Newman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael E. Newman more than expected).
Fields of papers citing papers by Michael E. Newman
This network shows the impact of papers produced by Michael E. Newman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael E. Newman. The network helps show where Michael E. Newman may publish in the future.
Co-authors
The 25 scholars most cited alongside Michael E. Newman, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 97 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 1987 | 363 | |
| 2 | 1987 | 127 | |
| 3 | 2004 | 93 | |
| 4 | 2007 | 81 | |
| 5 | 1998 | 75 | |
| 6 | 2000 | 65 | |
| 7 | 1999 | 63 | |
| 8 | Neurochemical mechanisms of action of ECS: evidence from in vivo studies. | 1998 | 62 |
| 9 | 1988 | 56 | |
| 10 | 1990 | 55 | |
| 11 | 2003 | 55 | |
| 12 | 1977 | 53 | |
| 13 | 1992 | 52 | |
| 14 | 1983 | 50 | |
| 15 | 1992 | 50 | |
| 16 | 2000 | 49 | |
| 17 | 1998 | 47 | |
| 18 | 2004 | 47 | |
| 19 | 1992 | 45 | |
| 20 | 2000 | 45 |
About Michael E. Newman
Michael E. Newman is a scholar working on Cellular and Molecular Neuroscience, Pharmacology, Psychiatry and Mental health, Behavioral Neuroscience and Physiology, having authored 97 papers that have together received 2.8k indexed citations. Recurring topics across this work include Treatment of Major Depression (27 papers), Neurotransmitter Receptor Influence on Behavior (25 papers), Neuroscience and Neuropharmacology Research (20 papers), Electroconvulsive Therapy Studies (13 papers), Adenosine and Purinergic Signaling (10 papers), Stress Responses and Cortisol (10 papers), Bipolar Disorder and Treatment (10 papers) and Receptor Mechanisms and Signaling (9 papers). The work is most often cited by research in Behavioral Neuroscience (205 citations), Cellular and Molecular Neuroscience (923 citations), Pharmacology (623 citations), Psychiatry and Mental health (739 citations) and Physiology (156 citations). Michael E. Newman has collaborated with scholars based in Israel, United States and United Kingdom. Frequent co-authors include Bernard Lerer, Eitan Gur, Robert Haim Belmaker, Eliyahu Dremencov, Baruch Shapira, HENRY MCILWAIN, Miron Baron, NEIL J. RISCH, Stuart F. Kushner and Louis D. Van de Kar. Their work appears in journals such as Neuropharmacology, JNCI Journal of the National Cancer Institute, European Journal of Pharmacology, Biochemical Pharmacology and Psychopharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.